法布瑞氏症 | |
---|---|
Alpha galactosidase - 这种蛋白质在法布瑞氏症患者身上产生异常 | |
分类和外部资源 | |
ICD-10 | E75.2 (ILDS E75.25) |
ICD-9-CM | 272.7 |
OMIM | 301500 |
DiseasesDB | 4638 |
eMedicine | neuro/579 derm/707 ped/2888 |
MeSH | D000795 |
法布瑞氏症(英语:Fabry disease,Fabry's disease,或Anderson-Fabry disease),一种X染色体上基因异常导致的X-连锁隐性遗传疾病。因体内负责制造α-galactosidase(a-GAL)酵素的基因缺陷,造成体内糖神经胺醇脂质(glycosphingolipid)无法代谢,不断堆积在细胞质及溶体中,而引发多处器官病变,严重时可能造成死亡。它的命名来自于它的发现者之一,乔纳斯·法布瑞(Johannes Fabry)。
症状
此病的临床症状多变。患者在儿童或青年期,手脚末端会产生间歇性的疼痛或感觉异常,有些患者形容如火烧般剧痛,在高温、季节变化、及运动后容易产生。经常被误诊为风湿病,关节炎,关节痛,生长痛或是心因性疼痛。
治疗方式
目前采取酵素替代疗法,让患者两周一次,注射α-galactosidase(a-GAL)酵素药剂,可以有效缓解病情。
参考文献
- James, William D.; Berger, Timothy G.; Elston, Dirk. Andrews' Diseases of the Skin: clinical Dermatology. Saunders Elsevier. 2006. ISBN 0-7216-2921-0.
- Schiffmann, Raphael; Kopp, Jeffrey B.; Austin, Howard A.; Sabnis, Sharda; Moore, David F.; Weibel, Thais; Balow, James E.; Brady, Roscoe O. Enzyme replacement therapy in Fabry disease: a randomized controlled trial. JAMA. June 2001, 285 (21): 2743–2749. PMID 11386930. doi:10.1001/jama.285.21.2743.
- Wilcox, William R.; Banikazemi, Maryam; Guffon, Nathalie; Waldek, Stephen; Lee, Philip; Linthorst, Gabor E.; Desnick, Robert J.; Germain, Dominique P. Long-term safety and efficacy of enzyme replacement therapy for Fabry disease. American Journal of Human Genetics. July 2004, 75 (1): 65–74. PMC 1182009 . PMID 15154115. doi:10.1086/422366.
外部链接
- Fabry Disease Information Page at NINDS
- Fabry disease at NLM Genetics Home Reference
- Fabry Registry
- Stroke in young Fabry patients
- Datagenno - Fabry Disease
- Support groups
- Focus on Fabry by Shire
- Fabry Community by Genzyme
- Fabry Support & Information Group (FSIG)
- Fabry support at MPS Society
- Canadian Fabry Association
- National Fabry Disease Foundation, USA
- Fabry Support Group Australia
- Fabry Support Group Poland by Pietka